Summary of Study ST001525
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001026. The data can be accessed directly via it's Project DOI: 10.21228/M82T3X This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001525 |
Study Title | Perfluorooctanesulfonic acid (PFOS) and perfluorohexanesulfonic acid (PFHxS) alter the blood lipidome and the hepatic proteome in a murine model of diet-induced obesity |
Study Summary | Perfluorooctanesulfonic acid (PFOS) and perfluorohexanesulfonic acid (PFHxS) alter the blood lipidome and the hepatic proteome in a murine model of diet-induced obesity |
Institute | University of Rhode Island;University of Georgia |
Department | Pharmaceutical and Biomedical Sciences |
Laboratory | Cummings/Slitt |
Last Name | Ingram |
First Name | Lishann |
Address | 250 West Green Street Athens, GA 30605 |
ingram@carnegiescience.edu | |
Phone | 706-542-3792 |
Submit Date | 2020-07-30 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzXML |
Analysis Type Detail | LC-MS |
Release Date | 2020-12-01 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR001614 |
Treatment Summary: | The mice were fed either a 10.5% kcal, low fat diet (LFD) (D12328, Research Diets, New Brunswick), or a 58% kcal, high fat diet (HFD) (D12331, Research Diets, New Brunswick). The mice were assigned to either diet alone, as controls, or to diet containing 0.0003% PFOS or 0.0003% PFHxS. The resulting treatment groups were as follows: low fat diet (LFD), high fat high carbohydrate diet (HFHC), LFD + PFOS (LPFNA), HFHC + PFOS (HPFOS), LFD + PFHxS (LPFHxS), and HFHC + PFHxS (HPFHxS) at n = 6 per treatment group. |